Niels Ejskjaer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Niels Ejskjaer has a total of 261 co-authors. Here are the top co-authors by number of shared publications:
- Johan Røikjer
Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark
17 shared publications - Christina Brock
Mech-Sense, Department of Gastroenterology, Aalborg University Hospital, Aalborg, Denmark
10 shared publications - Carsten Dahl Mørch
Aalborg University
9 shared publications - David C. Klonoff
Sutter Health Research Institute, Emeryville, CA, USA
7 shared publications - Jens Brøndum Frøkjær
Department of Clinical Medicine Aalborg University Aalborg Denmark
7 shared publications - Mette Krabsmark Borbjerg
Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark; Translational Pain Neuroscience and Precision Health, Aalborg University, Aalborg, Denmark
7 shared publications
Latest Publications
- 3 November 2026
- Published by Springer Nature in Diabetologia
- p. 1-8
Gout as a risk factor for lower-extremity amputation in diabetes: a nationwide, register-based case–control study
- 3 November 2026
- Published by Springer Nature in Diabetologia
- p. 1-8
Gout as a risk factor for lower-extremity amputation in diabetes: a nationwide, register-based case–control study
- Open Access
- 21 March 2026
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 40 (5) , 109311
Sleep quality and diabetic neuropathy: A review and exploratory meta-analysis
- 21 March 2026
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 40 (5) , 109311
Open AccessSleep quality and diabetic neuropathy: A review and exploratory meta-analysis
- Open Access
- 24 February 2026
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 22 (1) , 1-8
Impaired Dynamic Postural Control in People with Diabetes: An Exploratory Cross-Sectional Study Using Computerized Dynamic Posturography (Bertec)
BACKGROUND: This study assessed static and dynamic postural control in individuals with type 1 (T1D) and type 2 diabetes (T2D) using Computerized Dynamic Posturography (Bertec), hypothesizing that diabetes, especially with diabetic peripheral neuropathy (DPN), leads to significant impairments in postural stability. METHODS: A total of 94 participants with diabetes (T1D: n=49, T2D: n=45) and 94 age- and sex-matched controls underwent postural assessments using the Sensory Organization Test (SOT) and Motor Control Test (MCT). The SOT evaluated sensory system contributions (somatosensory,visual, vestibular), while the MCT assessed postural recovery responses. RESULTS: Both T1D and T2D groups exhibited impaired SOT performance compared to controls (P < .05). Type 1 diabetes showed impaired visual function (P < .05), while both groups demonstrated poorer postural stability in conditions requiring vestibular input (P < .05) and slower MCT response times (10 of 14 abnormal, P < .05). T2D participants relied excessively on visual input (preference function: P < .05). No significant associations were detected between DPN, body mass index, Hemoglobin A1c (HbA1c), or diabetes duration with postural control impairments. CONCLUSION: Diabetes impairs postural control, particularly in conditions that rely heavily on vestibular and visual inputs, regardless of DPN. Advanced tools like Bertec reveal real-world deficits, highlighting the potential value of these findings in informing future fall-prevention strategies for individuals with diabetes.
- 24 February 2026
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 22 (1) , 1-8
Open AccessImpaired Dynamic Postural Control in People with Diabetes: An Exploratory Cross-Sectional Study Using Computerized Dynamic Posturography (Bertec)
BACKGROUND: This study assessed static and dynamic postural control in individuals with type 1 (T1D) and type 2 diabetes (T2D) using Computerized Dynamic Posturography (Bertec), hypothesizing that diabetes, especially with diabetic peripheral neuropathy (DPN), leads to significant impairments in postural stability. METHODS: A total of 94 participants with diabetes (T1D: n=49, T2D: n=45) and 94 age- and sex-matched controls underwent postural assessments using the Sensory Organization Test (SOT) and Motor Control Test (MCT). The SOT evaluated sensory system contributions (somatosensory,visual, vestibular), while the MCT assessed postural recovery responses. RESULTS: Both T1D and T2D groups exhibited impaired SOT performance compared to controls (P < .05). Type 1 diabetes showed impaired visual function (P < .05), while both groups demonstrated poorer postural stability in conditions requiring vestibular input (P < .05) and slower MCT response times (10 of 14 abnormal, P < .05). T2D participants relied excessively on visual input (preference function: P < .05). No significant associations were detected between DPN, body mass index, Hemoglobin A1c (HbA1c), or diabetes duration with postural control impairments. CONCLUSION: Diabetes impairs postural control, particularly in conditions that rely heavily on vestibular and visual inputs, regardless of DPN. Advanced tools like Bertec reveal real-world deficits, highlighting the potential value of these findings in informing future fall-prevention strategies for individuals with diabetes.
- Open Access
- 10 February 2026
- Published by Springer Nature in Diabetologia
- Vol. 69 (6) , 1519-1531
Association of corneal nerve parameters with nerve abnormalities and neuropathic pain in prediabetes and type 2 diabetes: the Maastricht Study
Aims/hypothesis: Corneal confocal microscopy is a valuable technique for assessing neuropathy; however, whether it can distinguish painful from painless neuropathy remains uncertain and existing evidence is based on the results of smaller studies. This study assessed the association of corneal nerve parameters with abnormalities identified by electromyography (EMG) and neuropathic pain in a large population with and without (pre)diabetes. Methods: In this study we included cross-sectional data for 3425 participants from the Maastricht Study. Wide-field corneal confocal microscopy (WF-CCM) was performed using fully automated analysis of three corneal nerve parameters: corneal nerve branch density (CNBD), corneal nerve fibre density (CNFD) and corneal nerve fibre length (CNFL). An axonal degeneration composite score comprising compound muscle action potential amplitudes (peroneal and tibial) and the sensory nerve action potential amplitude of the sural nerve was created by categorising EMG amplitudes as normal or indicating minor (≤10th percentile), moderate (≤5th percentile) or severe (≤2.5th percentile) abnormalities. Neuropathic pain was determined as a modified Douleur Neuropathique en 4 Questions (DN4) interview score ≥3. Results: The mean age of the participants was 59.2 years; 51.6% were female, 15% had prediabetes (defined as impaired fasting glucose, impaired glucose tolerance or both) and 19% had type 2 diabetes. The median diabetes duration was 3.0 years. Regression analyses revealed statistically significant associations between the axonal degeneration EMG score and WF-CCM parameters (CNFL: β=−0.51 [95% CI −0.78, −0.24]; CNFD: β=−1.56 [95% CI −3.04, −0.08]; CNBD: β=−3.08 [95% CI −5.51, −0.64]; all p 0.1). Conclusions/interpretation: The study found associations between the axonal degeneration EMG score and WF-CCM, but no associations were observed between neuropathic pain and WF-CCM parameters, suggesting that WF-CCM has limited value in assessing neuropathic pain. Graphical
- 10 February 2026
- Published by Springer Nature in Diabetologia
- Vol. 69 (6) , 1519-1531
Open AccessAssociation of corneal nerve parameters with nerve abnormalities and neuropathic pain in prediabetes and type 2 diabetes: the Maastricht Study
Aims/hypothesis: Corneal confocal microscopy is a valuable technique for assessing neuropathy; however, whether it can distinguish painful from painless neuropathy remains uncertain and existing evidence is based on the results of smaller studies. This study assessed the association of corneal nerve parameters with abnormalities identified by electromyography (EMG) and neuropathic pain in a large population with and without (pre)diabetes. Methods: In this study we included cross-sectional data for 3425 participants from the Maastricht Study. Wide-field corneal confocal microscopy (WF-CCM) was performed using fully automated analysis of three corneal nerve parameters: corneal nerve branch density (CNBD), corneal nerve fibre density (CNFD) and corneal nerve fibre length (CNFL). An axonal degeneration composite score comprising compound muscle action potential amplitudes (peroneal and tibial) and the sensory nerve action potential amplitude of the sural nerve was created by categorising EMG amplitudes as normal or indicating minor (≤10th percentile), moderate (≤5th percentile) or severe (≤2.5th percentile) abnormalities. Neuropathic pain was determined as a modified Douleur Neuropathique en 4 Questions (DN4) interview score ≥3. Results: The mean age of the participants was 59.2 years; 51.6% were female, 15% had prediabetes (defined as impaired fasting glucose, impaired glucose tolerance or both) and 19% had type 2 diabetes. The median diabetes duration was 3.0 years. Regression analyses revealed statistically significant associations between the axonal degeneration EMG score and WF-CCM parameters (CNFL: β=−0.51 [95% CI −0.78, −0.24]; CNFD: β=−1.56 [95% CI −3.04, −0.08]; CNBD: β=−3.08 [95% CI −5.51, −0.64]; all p 0.1). Conclusions/interpretation: The study found associations between the axonal degeneration EMG score and WF-CCM, but no associations were observed between neuropathic pain and WF-CCM parameters, suggesting that WF-CCM has limited value in assessing neuropathic pain. Graphical
- 17 November 2025
- Published by Wiley in Muscle & Nerve
- Vol. 73 (1) , 72-78
Corneal Immune Cells and Their Relation to Diabetic Peripheral Neuropathy and Neuropathic Pain
Introduction/Aims: As corneal dendritic cells (DCs) are immune cells that can reflect systemic inflammatory activity, this study aimed to investigate whether the density and maturity of corneal DCs are associated with diabetes, diabetic peripheral neuropathy (DPN), and neuropathic pain. Methods: Participants included individuals with type 1 diabetes mellitus (T1DM) and painful DPN ( n = 19), T1DM and painless DPN ( n = 15), T1DM without DPN ( n = 19), and healthy controls ( n = 20). Corneal confocal microscopy was used to quantify and categorize DCs as either mature or immature and based on their proximity to corneal nerves. Results: No significant differences between groups were observed in total DC density ( p = 0.34). Subgroup analysis revealed distinct patterns in which participants with DPN (regardless of pain status) exhibited a higher density of immature DCs distant from corneal nerves compared to those without DPN (14.4 [6.64–37.5] vs. 3.75 [0–17.7] no./mm 2 , p < 0.05). Healthy controls had a greater density of immature DCs near the nerves compared to the T1DM + DPN group (2.8 [0–8.44] vs. 8.3 [3.12–15.1] no./mm 2 ), while the T1DM + DPN group had a higher density than the painful DPN (3.1 [1.25–5.62] no./mm 2 ). For mature DCs near the nerves, individuals with painful DPN (2.5 [1.4–3.12] no./mm 2 ) had a lower density compared to all other groups. Discussion: This study demonstrates distinct patterns of corneal DC distribution in relation to painful and painless DPN. The findings suggest that immune‐mediated mechanisms may play a role in the development of neuropathy and neuropathic pain in diabetes. The pathophysiological significance remains to be clarified. Trial Registration: ClinicalTrials.gov: NCT04078516.
- 17 November 2025
- Published by Wiley in Muscle & Nerve
- Vol. 73 (1) , 72-78
Corneal Immune Cells and Their Relation to Diabetic Peripheral Neuropathy and Neuropathic Pain
Introduction/Aims: As corneal dendritic cells (DCs) are immune cells that can reflect systemic inflammatory activity, this study aimed to investigate whether the density and maturity of corneal DCs are associated with diabetes, diabetic peripheral neuropathy (DPN), and neuropathic pain. Methods: Participants included individuals with type 1 diabetes mellitus (T1DM) and painful DPN ( n = 19), T1DM and painless DPN ( n = 15), T1DM without DPN ( n = 19), and healthy controls ( n = 20). Corneal confocal microscopy was used to quantify and categorize DCs as either mature or immature and based on their proximity to corneal nerves. Results: No significant differences between groups were observed in total DC density ( p = 0.34). Subgroup analysis revealed distinct patterns in which participants with DPN (regardless of pain status) exhibited a higher density of immature DCs distant from corneal nerves compared to those without DPN (14.4 [6.64–37.5] vs. 3.75 [0–17.7] no./mm 2 , p < 0.05). Healthy controls had a greater density of immature DCs near the nerves compared to the T1DM + DPN group (2.8 [0–8.44] vs. 8.3 [3.12–15.1] no./mm 2 ), while the T1DM + DPN group had a higher density than the painful DPN (3.1 [1.25–5.62] no./mm 2 ). For mature DCs near the nerves, individuals with painful DPN (2.5 [1.4–3.12] no./mm 2 ) had a lower density compared to all other groups. Discussion: This study demonstrates distinct patterns of corneal DC distribution in relation to painful and painless DPN. The findings suggest that immune‐mediated mechanisms may play a role in the development of neuropathy and neuropathic pain in diabetes. The pathophysiological significance remains to be clarified. Trial Registration: ClinicalTrials.gov: NCT04078516.
- 7 November 2025
- Published by Springer Nature in Acta Diabetologica
- Vol. 63 (2) , 193-199
Symptom-driven co-existence of diabetic autonomic neuropathy, peripheral neuropathy, and painful neuropathy
Aims Diabetic Autonomic Neuropathy (DAN) and Diabetic Peripheral Neuropathy (DPN) are distinct complications of diabetes, but their co-existence remains underexplored. This study aimed to investigate the symptom-driven co-existence of DAN, DPN, and painful DPN. Methods In November 2022, an electronic survey was distributed to everyone with diabetes in the North Denmark Region (n = 29,155). The survey included demographic data, and validated questionnaires: the Michigan Neuropathy Screening Instrument (MNSI), Composite Autonomic Symptom Score-31 (COMPASS-31), and Douleur Neuropathique 4 Interview (DN4i). DPN was defined as MNSI ≥ 4, painful DPN as bilateral foot pain with DN4i ≥ 3, and DAN as COMPASS-31 ≥ 16. DAN was further stratified into: symptoms of autonomic dysfunction (SAD)- (< 16), SAD + (16–31), and SAD + + (≥ 32). Results Of 9,913 respondents, 7,321 provided complete data. Mean age was 64.8 yearsand 86.3% had type 2 diabetes. DPN prevalence among those with DAN was 44.6% in type 1 and 39.6% in type 2 diabetes. DPN prevalence rose with DAN severity: 11.1% in SAD-, 26.4% in SAD + , and 58.6% in SAD + + (p < 0.01). Painful DPN followed a similar trend, increasing from 8.0% in SAD- to 50.2% in SAD + + (p < 0.01). Linear regression demonstrated a strong association between COMPASS-31 and MNSI scores (p < 0.001), indicating that higher autonomic symptom burden was associated with greater severity of peripheral neuropathy. Conclusions DAN, DPN, and painful DPN frequently co-exist. Increasing DAN symptom severity is associated with higher prevalence of both DPN and neuropathic pain and showed a strong linear association with the severity of peripheral DPN, suggesting shared pathophysiological mechanisms beyond isolated small fiber involvement.
- 7 November 2025
- Published by Springer Nature in Acta Diabetologica
- Vol. 63 (2) , 193-199
Symptom-driven co-existence of diabetic autonomic neuropathy, peripheral neuropathy, and painful neuropathy
Aims Diabetic Autonomic Neuropathy (DAN) and Diabetic Peripheral Neuropathy (DPN) are distinct complications of diabetes, but their co-existence remains underexplored. This study aimed to investigate the symptom-driven co-existence of DAN, DPN, and painful DPN. Methods In November 2022, an electronic survey was distributed to everyone with diabetes in the North Denmark Region (n = 29,155). The survey included demographic data, and validated questionnaires: the Michigan Neuropathy Screening Instrument (MNSI), Composite Autonomic Symptom Score-31 (COMPASS-31), and Douleur Neuropathique 4 Interview (DN4i). DPN was defined as MNSI ≥ 4, painful DPN as bilateral foot pain with DN4i ≥ 3, and DAN as COMPASS-31 ≥ 16. DAN was further stratified into: symptoms of autonomic dysfunction (SAD)- (< 16), SAD + (16–31), and SAD + + (≥ 32). Results Of 9,913 respondents, 7,321 provided complete data. Mean age was 64.8 yearsand 86.3% had type 2 diabetes. DPN prevalence among those with DAN was 44.6% in type 1 and 39.6% in type 2 diabetes. DPN prevalence rose with DAN severity: 11.1% in SAD-, 26.4% in SAD + , and 58.6% in SAD + + (p < 0.01). Painful DPN followed a similar trend, increasing from 8.0% in SAD- to 50.2% in SAD + + (p < 0.01). Linear regression demonstrated a strong association between COMPASS-31 and MNSI scores (p < 0.001), indicating that higher autonomic symptom burden was associated with greater severity of peripheral neuropathy. Conclusions DAN, DPN, and painful DPN frequently co-exist. Increasing DAN symptom severity is associated with higher prevalence of both DPN and neuropathic pain and showed a strong linear association with the severity of peripheral DPN, suggesting shared pathophysiological mechanisms beyond isolated small fiber involvement.
- 13 October 2025
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 478, 123730
Response to Letter to the Editor: Concerns about generalizability in MRI-based neuropathy classification
- 13 October 2025
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 478, 123730
Response to Letter to the Editor: Concerns about generalizability in MRI-based neuropathy classification
- Open Access
- 16 September 2025
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 478, 123701
Multimodal MRI analysis selecting key brain features for machine learning based classification of diabetic neuropathic pain and phenotypes
- 16 September 2025
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 478, 123701
Open AccessMultimodal MRI analysis selecting key brain features for machine learning based classification of diabetic neuropathic pain and phenotypes
- 11 September 2025
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 19 (6) , 1650-1670
Machine Learning to Diagnose Complications of Diabetes
Machine learning (ML) uses computer systems to develop statistical algorithms and statistical models that can draw inferences from demographic data, structured behavioral data, continuous glucose monitor (CGM) tracings, laboratory data, cardiovascular and neurological physiology measurements, and images from a variety of sources. ML is becoming increasingly used to diagnose complications of diabetes based on these types of datasets. In this article, we review the current status, barriers to progress, and future prospects for using ML to diagnose seven complications of diabetes, including five traditional complications, one set of other systemic complications, and one prediction that can result in favorable or unfavorable outcomes. The complications include (1) diabetic retinopathy, (2) diabetic nephropathy, (3) peripheral neuropathy, (4) autonomic neuropathy, (5) diabetic foot ulcers, and (6) other systemic complications. The prediction is for outcomes in hospitalized patients with diabetes. ML for these purposes is in its infancy, as evidenced by only a limited number of products having received regulatory clearance at this time. However, as multicenter reference datasets become available, it will become possible to train algorithms on increasingly larger and more complex datasets and patterns so that diagnoses and predictions will become increasingly accurate. The use of novel choices of images and imaging technologies will contribute to progress in this field. ML is poised to become a widely used tool for the diagnosis of complications and predictions of outcomes and glycemia in people with diabetes.
- 11 September 2025
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 19 (6) , 1650-1670
Machine Learning to Diagnose Complications of Diabetes
Machine learning (ML) uses computer systems to develop statistical algorithms and statistical models that can draw inferences from demographic data, structured behavioral data, continuous glucose monitor (CGM) tracings, laboratory data, cardiovascular and neurological physiology measurements, and images from a variety of sources. ML is becoming increasingly used to diagnose complications of diabetes based on these types of datasets. In this article, we review the current status, barriers to progress, and future prospects for using ML to diagnose seven complications of diabetes, including five traditional complications, one set of other systemic complications, and one prediction that can result in favorable or unfavorable outcomes. The complications include (1) diabetic retinopathy, (2) diabetic nephropathy, (3) peripheral neuropathy, (4) autonomic neuropathy, (5) diabetic foot ulcers, and (6) other systemic complications. The prediction is for outcomes in hospitalized patients with diabetes. ML for these purposes is in its infancy, as evidenced by only a limited number of products having received regulatory clearance at this time. However, as multicenter reference datasets become available, it will become possible to train algorithms on increasingly larger and more complex datasets and patterns so that diagnoses and predictions will become increasingly accurate. The use of novel choices of images and imaging technologies will contribute to progress in this field. ML is poised to become a widely used tool for the diagnosis of complications and predictions of outcomes and glycemia in people with diabetes.